Anixa Biosciences Inc (NASDAQ:ANIX)
| 3.25 Delayed Data As of Jul 10 |  +0.33 / +11.30%Today’s Change | 1.33 Today|||52-Week Range 5.45 | -0.91% Year-to-Date |
Latest ANIX News | Press Releases
No recent news for Anixa Biosciences Inc.
Today’s Trading
| Previous close | 2.92 |
| Today’s open | 3.30 |
| Day’s range | 3.10 - 3.50 |
| Volume | 81,314 |
| Average volume (3 months) | 312,992 |
| Market cap | $77.6M |
Data as of 3:59pm ET, 07/10/2020
Growth & Valuation
| Earnings growth (last year) | +25.89% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -77.53% |
| P/E ratio | NM |
| Price/Sales | 306.35 |
| Price/Book | 12.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONVOOrganovo Holdings In... | -0.01 | -1.77% |
| INMBINmune Bio Inc | +0.95 | +15.57% |
| ETTXEntasis Therapeutics... | +0.16 | +5.73% |
| ARMPArmata Pharmaceutica... | -0.01 | -0.25% |
Data as of 3:59pm ET, 07/10/2020
Financials
| Next reporting date | September 15, 2020 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $250.0K |
| Annual profit (last year) | -$11.6M |
| Net profit margin | -4,658.82% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Jose, California |
Forecasts
